U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H24N4O4
Molecular Weight 384.429
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ISTRADEFYLLINE

SMILES

CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O

InChI

InChIKey=IQVRBWUUXZMOPW-PKNBQFBNSA-N
InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+

HIDE SMILES / InChI

Molecular Formula C20H24N4O4
Molecular Weight 384.429
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:52:37 UTC 2023
Edited
by admin
on Sat Dec 16 17:52:37 UTC 2023
Record UNII
2GZ0LIK7T4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ISTRADEFYLLINE
DASH   INN   JAN   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
KW-6002
Code English
(E)-8-(3,4-DIMETHOXYSTYRYL)-1,3-DIETHYL-7-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
Systematic Name English
Istradefylline [WHO-DD]
Common Name English
8-[(1E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
Systematic Name English
1H-PURINE-2,6-DIONE, 8-((1E)-2-(3,4-DIMETHOXYPHENYL)ETHENYL)-1,3-DIETHYL-3,7-DIHYDRO-7-METHYL-
Systematic Name English
ISTRADEFYLLINE [USAN]
Common Name English
ISTRADEFYLLINE [MI]
Common Name English
ISTRADEFYLLINE [JAN]
Common Name English
istradefylline [INN]
Common Name English
NOURIANZ
Brand Name English
ISTRADEFYLLINE [ORANGE BOOK]
Common Name English
NOURIAST
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C38149
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
Code System Code Type Description
MERCK INDEX
m6559
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY Merck Index
JAPANESE REVIEW
NOURIAST
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY APPROVED MARCH 2013
PUBCHEM
5311037
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
RXCUI
2199015
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
INN
8387
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
DRUG BANK
DB11757
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
ChEMBL
CHEMBL431770
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
CAS
155270-99-8
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
DAILYMED
2GZ0LIK7T4
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
EPA CompTox
DTXSID7057652
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
WIKIPEDIA
ISTRADEFYLLINE
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
FDA UNII
2GZ0LIK7T4
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
MESH
C111599
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
NCI_THESAURUS
C73268
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
SMS_ID
100000152133
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
EVMPD
SUB126676
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
DRUG CENTRAL
4882
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
USAN
OO-61
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
IUPHAR
5608
Created by admin on Sat Dec 16 17:52:40 UTC 2023 , Edited by admin on Sat Dec 16 17:52:40 UTC 2023
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
MINOR
METABOLIC ENZYME -> SUBSTRATE
MINOR
METABOLIC ENZYME -> SUBSTRATE
MINOR
TARGET->WEAK INHIBITOR
Ki
METABOLIC ENZYME -> SUBSTRATE
MINOR
BINDER->LIGAND
BINDING
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
MINOR
EXCRETED UNCHANGED
AMOUNT ADMINISTERED
FECAL
TARGET->WEAK INHIBITOR
Ki
METABOLIC ENZYME -> SUBSTRATE
MINOR
Related Record Type Details
METABOLITE -> PARENT
FECAL
METABOLITE -> PARENT
FECAL
METABOLITE -> PARENT
FECAL
METABOLITE -> PARENT
PLASMA; URINE
METABOLITE -> PARENT
FECAL
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
FECAL
METABOLITE -> PARENT
PLASMA
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Tmax PHARMACOKINETIC ORAL ADMINISTRATION

Biological Half-life PHARMACOKINETIC